⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of RemediumOne and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
RemediumOne
↗Colombo, Sri Lanka
RemediumOne is a pioneering clinical research organization (CRO) based in Sri Lanka, founded in 2009. The company provides comprehensive clinical trial management services, including protocol development, site selection, patient recruitment and retention, data management, and pharmacovigilance, serving global pharmaceutical companies, CROs, and academic institutions.
With over 15 years of experience, the company manages a network of over 80 investigator sites and collaborates with more than 300 investigators across diverse therapeutic areas. They are known for leveraging Sri Lanka's large patient population and robust healthcare infrastructure to accelerate clinical trial timelines while adhering to ISO and ICH-GCP standards.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:2009
Ownership:private
Status:operating
PIPELINE
Active Trials:60
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Duke-NUS Graduate Medical School, University of Notre Dame (CRC), SC Johnson (AEGIS program)
COMPETITION
Position:Niche Player
Competitors:WuXi AppTec, ANI Pharmaceuticals, EVERSANA, DM Clinical Research
LEADERSHIP
Key Executives:
Samantha Ranatunga - CEO
Karthi Gajendran - Chairman
Board Members:Karthi Gajendran, Priyanga Gunasekera, Saliya Wickramasuriya, Samantha Ranatunga
LINKS
Website:remediumone.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with RemediumOne. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.